Literature DB >> 20434730

Comparative effectiveness of medical interventions in adults versus children.

Despina G Contopoulos-Ioannidis1, Maria S Baltogianni, John P A Ioannidis.   

Abstract

OBJECTIVE: To estimate the comparative effectiveness of medical interventions in adults versus children. STUDY
DESIGN: We identified from the Cochrane Database of Systematic Reviews (Issue 1, 2007) meta-analyses with data on at least 1 adult and 1 pediatric randomized trial with binary primary efficacy outcome. For each meta-analysis, we calculated the summary odds ratio of the adult trials and the pediatric trials, respectively; the relative odds ratio (ROR) of the adult versus pediatric odds ratios per meta-analysis; and the summary ROR across all meta-analyses. ROR <1 means that the experimental intervention is more unfavorable in children than adults.
RESULTS: Across 128 eligible meta-analyses (1051 adult and 343 pediatric trials), the summary ROR did not show a statistically significant difference between adults and children (0.96; 95% confidence intervals, 0.86 to 1.08). However, in all meta-analyses except for 1, the individual ROR's 95% confidence intervals could not exclude a relative difference in efficacy over 20%. In two-thirds, the relative difference in observed point estimates exceeded 50%. Nine statistically significant discrepancies were identified; 4 of them were also clinically important.
CONCLUSIONS: Treatment effects are on average similar in adults and children, but available evidence leaves large uncertainty about their relative efficacy. Clinically important discrepancies may occur. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20434730     DOI: 10.1016/j.jpeds.2010.02.011

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Pediatric versus adult drug trials for conditions with high pediatric disease burden.

Authors:  Florence T Bourgeois; Srinivas Murthy; Catia Pinto; Karen L Olson; John P A Ioannidis; Kenneth D Mandl
Journal:  Pediatrics       Date:  2012-07-23       Impact factor: 7.124

2.  New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products.

Authors:  Ann-Katrine Birkelund Mogensen; Helle Christiansen; Marie Louise De Bruin; Christine Erikstrup Hallgreen
Journal:  Paediatr Drugs       Date:  2022-08-13       Impact factor: 3.930

Review 3.  Clinical trials in children.

Authors:  Pathma D Joseph; Jonathan C Craig; Patrina H Y Caldwell
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

4.  Comparison of nuisance parameters in pediatric versus adult randomized trials: a meta-epidemiologic empirical evaluation.

Authors:  Ben Vandermeer; Ingeborg van der Tweel; Marijke C Jansen-van der Weide; Stephanie S Weinreich; Despina G Contopoulos-Ioannidis; Dirk Bassler; Ricardo M Fernandes; Lisa Askie; Haroon Saloojee; Paola Baiardi; Susan S Ellenberg; Johanna H van der Lee
Journal:  BMC Med Res Methodol       Date:  2018-01-10       Impact factor: 4.615

5.  Do systematic reviews on pediatric topics need special methodological considerations?

Authors:  Mufiza Farid-Kapadia; Lisa Askie; Lisa Hartling; Despina Contopoulos-Ioannidis; Zulfiqar A Bhutta; Roger Soll; David Moher; Martin Offringa
Journal:  BMC Pediatr       Date:  2017-03-06       Impact factor: 2.125

6.  Are child-centric aspects in newborn and child health systematic review and meta-analysis protocols and reports adequately reported?-two systematic reviews.

Authors:  Mufiza Farid-Kapadia; Kariym C Joachim; Chrinna Balasingham; April Clyburne-Sherin; Martin Offringa
Journal:  Syst Rev       Date:  2017-03-06

7.  Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study.

Authors:  Patrick Liu; John P A Ioannidis; Joseph S Ross; Sanket S Dhruva; Anita T Luxkaranayagam; Vasilis Vasiliou; Joshua D Wallach
Journal:  BMC Med       Date:  2019-10-21       Impact factor: 8.775

8.  High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.

Authors:  Brechkerts Lieske Angruni Tukayo; Bruce Sunderland; Richard Parsons; Petra Czarniak
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

9.  Patient, Caregiver, and Clinician Participation in Prioritization of Research Questions in Pediatric Hospital Medicine.

Authors:  Peter J Gill; Ann Bayliss; Aubrey Sozer; Francine Buchanan; Karen Breen-Reid; Kim De Castris-Garcia; Mairead Green; Michelle Quinlan; Noel Wong; Shelley Frappier; Katherine Cowan; Carol Chan; Dana Arafeh; Mohammed Rashid Anwar; Colin Macarthur; Patricia C Parkin; Eyal Cohen; Sanjay Mahant
Journal:  JAMA Netw Open       Date:  2022-04-01

10.  Comparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological study.

Authors:  Valérie Seegers; Ludovic Trinquart; Isabelle Boutron; Philippe Ravaud
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.